Mylan Pharmaceuticals Inc. has recalled 10,390 bottles of Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray because the glass bottles may be defective. There is a potential for broken glass to be present in the neck area of the 23-gram bottles. This prescription medication, used for seasonal allergies, was distributed nationwide across the United States. Consumers should immediately check their prescription bottles to see if they are part of the affected lot and contact their healthcare provider for guidance on continuing treatment.
The presence of broken glass in the neck of the bottle could lead to glass fragments being discharged during use or causing injury to the user's hands or nasal passages during administration.
Healthcare provider consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.